Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Azacitidine plus phenylbutyrate may help leukemia cells develop into normal white
blood cells.
PURPOSE: Phase I trial to study the effectiveness of combining azacitidine and phenylbutyrate
in treating patients who have acute myeloid leukemia or myelodysplastic syndrome.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins